0001942459-24-000007.txt : 20240307 0001942459-24-000007.hdr.sgml : 20240307 20240307173635 ACCESSION NUMBER: 0001942459-24-000007 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240305 FILED AS OF DATE: 20240307 DATE AS OF CHANGE: 20240307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bornstein Jonathan CENTRAL INDEX KEY: 0001942459 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41314 FILM NUMBER: 24731500 MAIL ADDRESS: STREET 1: 1180 PAGE AVENUE CITY: FREMONT STATE: CA ZIP: 94538 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Amprius Technologies, Inc. CENTRAL INDEX KEY: 0001899287 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690] ORGANIZATION NAME: 04 Manufacturing IRS NUMBER: 981591811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1180 PAGE AVENUE CITY: FREMONT STATE: CA ZIP: 94538 BUSINESS PHONE: (800) 425-8803 MAIL ADDRESS: STREET 1: 1180 PAGE AVENUE CITY: FREMONT STATE: CA ZIP: 94538 FORMER COMPANY: FORMER CONFORMED NAME: Kensington Capital Acquisition Corp. IV DATE OF NAME CHANGE: 20211214 4 1 wk-form4_1709850983.xml FORM 4 X0508 4 2024-03-05 0 0001899287 Amprius Technologies, Inc. AMPX 0001942459 Bornstein Jonathan C/O AMPRIUS TECNOLOGIES, INC., 1180 PAGE AVENUE FREMONT CA 94538 0 1 0 0 President of Amprius Lab 1 Common stock 2024-03-05 4 M 0 109800 0.05 A 109800 D Common stock 2024-03-05 4 S 0 109800 2.9186 D 0 D Common stock 2024-03-06 4 M 0 40200 0.05 A 40200 D Common stock 2024-03-06 4 S 0 40200 2.7756 D 0 D Stock Option (right to buy) 0.05 2024-03-05 4 M 0 109800 0 D 2022-09-14 2027-03-15 Common stock 109800 1174051 D Stock Option (right to buy) 0.05 2024-03-06 4 M 0 40200 0 D 2022-09-14 2027-03-15 Common stock 40200 1133851 D The exercises and sales reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2023. The price reported in Column 4 is an average execution price. These shares were sold in multiple transactions at prices ranging from $2.87 to $3, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is an average execution price. These shares were sold in multiple transactions at prices ranging from $2.72 to $2.90, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. /s/ Sandra Wallach, attorney-in-fact on behalf of Jonathan Bornstein 2024-03-07